Medication Brand Names Beginning with ‘R’, Page 25

Page 25 of 132 « First Page « … 5 10 15 20 … 23 24 25 26 27 … 30 35 40 45 50 … » Last Page »

Ranitidine

Ranitidine tablets USP are indicated in: 1. Short-term treatment of active duodenal ulcer. Most patients heal within 4 weeks. Studies available to date have not assessed the safety of…

Glenmark Pharmaceuticals Inc., USA7 December 2018

Ranitidine

Ranitidine Tablets are indicated in: 1. Short-term treatment of active duodenal ulcer. Most patients heal within 4 weeks. Studies available to date have not assessed the safety of…

QPharma Inc27 December 2019

Ranitidine

Ranitidine Tablets USP are indicated in: Short-term treatment of active duodenal ulcer. Most patients heal within 4 weeks. Studies available to date have not assessed the safety of…

Medsource Pharmaceuticals27 December 2019

Ranitidine

Ranitidine Tablets USP are indicated in: 1. Short-term treatment of active duodenal ulcer. Most patients heal within 4 weeks. Studies available to date have not assessed the safety of…

Aphena Pharma Solutions – Tennessee, LLC20 December 2019

Ranitidine

Ranitidine tablets USP are indicated in: 1. Short-term treatment of active duodenal ulcer. Most patients heal within 4 weeks. Studies available to date have not assessed the safety of…

A-S Medication Solutions18 January 2020

Page 25 of 132 « First Page « … 5 10 15 20 … 23 24 25 26 27 … 30 35 40 45 50 … » Last Page »

FDA Medwatch

Nostrum Laboratories, Inc. Expands Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Sun, 24 Jan 2021. Nostrum Laboratories, Inc. is voluntarily recalling one lot of Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) to the consumer level. The Metformin HCl Extended Release Tablets, USP 750 mg (generic…
Boston Scientific Announces LOTUS Edge™ Aortic Valve System Voluntary Recall and Product Discontinuation
Sun, 10 Jan 2021. Boston Scientific Corporation (NYSE: BSX) has announced it has initiated a global, voluntary recall of all unused inventory of the LOTUS Edge™ Aortic Valve System due to complexities associated with the product delivery system. The voluntary…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.